BioInterphase Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $641K

  • Investors
  • 7

BioInterphase General Information

Description

Developer of surface treatment technology designed to improve the efficiency of industrial cooling systems. The company's technology works by creating a single molecule monolayer on cooling system hardware, enabling clients to get access to improved interaction between cooling water and tubing and inhibiting biological adhesions and scale deposits.

Contact Information

Website
www.biointerphase.com
Formerly Known As
SurfMatters/Oxi-DENT, Interphase Materials
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 35 Wilson Street
  • Pittsburgh, PA 15223
  • United States
+1 (412)
Primary Industry
Electronic Equipment and Instruments
Other Industries
Other Commercial Products
Other Hardware
Vertical(s)
Nanotechnology, TMT
Corporate Office
  • 35 Wilson Street
  • Pittsburgh, PA 15223
  • United States
+1 (412)

BioInterphase Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioInterphase Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Grant 01-Jan-2022 $641K Completed Generating Revenue
12. Grant 31-Dec-2021 Completed Generating Revenue
11. Seed Round 30-Oct-2020 Completed Generating Revenue
10. Accelerator/Incubator 15-May-2020 Completed Generating Revenue
9. Debt - PPP 13-Apr-2020 Completed Generating Revenue
8. Grant 01-Jan-2020 Completed Generating Revenue
7. Angel (individual) 18-Apr-2019 Completed Generating Revenue
6. Grant 05-Oct-2017 Completed Generating Revenue
5. Grant 08-Jul-2016 $80K $120K Completed Startup
4. Grant $25K $120K Completed Startup
To view BioInterphase’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

BioInterphase Patents

  • 6

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

BioInterphase Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3697860-A2 Surface treatment Inactive 14-Aug-2017
AU-2018410240-A1 Surface treatment Inactive 14-Aug-2017
US-20200231842-A1 Surface treatment Active 14-Aug-2017
EP-3697860-A4 Surface treatment Inactive 14-Aug-2017
US-12146071-B2 Surface treatment Active 14-Aug-2017 C09D183/06
To view BioInterphase’s complete patent history, request access »

BioInterphase Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioInterphase Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
U.S. Department of Energy Government
U.S. Department of Transportation Government
U. S. National Science Foundation Government
United States Department of Defense Government
AlphaLab Gear Accelerator/Incubator Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

BioInterphase FAQs

  • When was BioInterphase founded?

    BioInterphase was founded in 2015.

  • Where is BioInterphase headquartered?

    BioInterphase is headquartered in Pittsburgh, PA.

  • What is the size of BioInterphase?

    BioInterphase has 7 total employees.

  • What industry is BioInterphase in?

    BioInterphase’s primary industry is Electronic Equipment and Instruments.

  • Is BioInterphase a private or public company?

    BioInterphase is a Private company.

  • What is BioInterphase’s current revenue?

    The current revenue for BioInterphase is .

  • How much funding has BioInterphase raised over time?

    BioInterphase has raised $1.32M.

  • Who are BioInterphase’s investors?

    U.S. Department of Energy, U.S. Department of Transportation, U. S. National Science Foundation, United States Department of Defense, and AlphaLab Gear are 5 of 7 investors who have invested in BioInterphase.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »